SCHEMBL9763407

SCHEMBL9763407

COC(=O)c1ccc(CCCOCCCCCCBr)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.60
CYP4F2 P78329 1/20 0.59
LOXL2 Q9Y4K0 1/20 0.49
CCR6 P51684 1/20 0.46
HKDC1 Q2TB90 1/20 0.46
MAPT P10636 3/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45
CKS1B P61024 1/20 0.45
SKP2 Q13309 1/20 0.45
HIF1A Q16665 1/20 0.45
HSD17B10 Q99714 1/20 0.45
THRA P10827 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2173758 0.88 CYP4A11 (0.75) CYP4A11CYP4F2LOXL2CCR6HKDC1
SCHEMBL2162519 0.88 CYP4A11 (0.72) CYP4A11CYP4F2LOXL2CCR6HKDC1
SCHEMBL9762683 0.86 CA12 (0.47) CYP4A11CYP4F2MAPTALDH1A1TP53
SCHEMBL18106036 0.85 CYP4A11 (0.79) CYP4A11CYP4F2LOXL2CCR6HKDC1
SCHEMBL9763014 0.85 ALDH1A1 (0.51) MAPTALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL19580918 0.84 CYP4A11 (0.61) CYP4A11CYP4F2LOXL2CCR6HKDC1
SCHEMBL12354618 0.84 CYP4A11 (0.65) CYP4A11CYP4F2LOXL2MAPTALDH1A1
SCHEMBL18106009 0.84 CYP4A11 (0.74) CYP4A11CYP4F2LOXL2CCR6HKDC1
SCHEMBL9763639 0.83 RARB (0.50) CYP4A11CYP4F2MAPTALDH1A1TP53
SCHEMBL9763633 0.82 SPHK1 (0.44) ALDH1A1THRATHRBSPHK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990505-A Treating asthma, bronchitis; adrenergic stimulants GLAXO GROUP LIMITED (GB) 1991-02-05 US disclosed
US-4853381-A Ethanolamine compounds GLAXO GROUP LIMITED (GB) 1989-08-01 US disclosed
EP-0223410-A2 Ethanolamine Derivatives GLAXO GROUP LIMITED (GB) 1987-05-27 EP disclosed